Your browser doesn't support javascript.
loading
Infiltration of tumor-associated macrophages is involved in tumor programmed death-ligand 1 expression in early lung adenocarcinoma.
Shima, Toshiyuki; Shimoda, Masayuki; Shigenobu, Takao; Ohtsuka, Takashi; Nishimura, Tomoyasu; Emoto, Katsura; Hayashi, Yuichiro; Iwasaki, Tatsuro; Abe, Takayuki; Asamura, Hisao; Kanai, Yae.
  • Shima T; Department of Pathology, Keio University School of Medicine, Tokyo, Japan.
  • Shimoda M; Division of Thoracic Surgery, Keio University School of Medicine, Tokyo, Japan.
  • Shigenobu T; Department of Pathology, Keio University School of Medicine, Tokyo, Japan.
  • Ohtsuka T; Department of Pathology, Keio University School of Medicine, Tokyo, Japan.
  • Nishimura T; Division of Thoracic Surgery, Keio University School of Medicine, Tokyo, Japan.
  • Emoto K; Division of Thoracic Surgery, Department of Surgery, Jikei University School of Medicine, Tokyo, Japan.
  • Hayashi Y; Health Center, Keio University, Tokyo, Japan.
  • Iwasaki T; Division of Diagnostic Pathology, Keio University Hospital, Tokyo, Japan.
  • Abe T; Division of Diagnostic Pathology, Keio University Hospital, Tokyo, Japan.
  • Asamura H; Department of Pathology, Keio University School of Medicine, Tokyo, Japan.
  • Kanai Y; School of Data Science, Yokohama City University, Yokohama, Japan.
Cancer Sci ; 111(2): 727-738, 2020 Feb.
Article en En | MEDLINE | ID: mdl-31821665
ABSTRACT
Programmed death-ligand 1 (PD-L1) is an immune modulator that promotes immunosuppression by binding to programmed death-1 of T-lymphocytes. Although tumor cell PD-L1 expression has been shown to be associated with the clinical response to anti-PD-L1 antibodies, its concise regulatory mechanisms remain elusive. In this study, we evaluated the associations of tumor PD-L1 expression and immune cell infiltrating patterns in 146 cases of early lung adenocarcinoma (AC) to investigate the possible extrinsic regulation of tumor PD-L1 by immune cells. Using immunohistochemistry, cell surface PD-L1 expression in tumor cells was observed in 18.5% of stage 0-IA lung AC patients. Tumor PD-L1 positivity was significantly associated with stromal invasion, which was accompanied by increased tumor-associated macrophages (TAM), CD8+ cytotoxic T cells and FoxP3+ regulatory T cells. Among these immune cells, TAM and CD8+ T cells significantly accumulated in PD-L1-positive carcinoma cell areas, which showed a tumor cell nest-infiltrating pattern. Although CD8+ T cells are known to induce tumor PD-L1 expression via interferon-É£ production, the increased TAM within tumors were also associated with tumor cell PD-L1 positivity, independently of CD8+ T cell infiltration. Our in vitro experiments revealed that PD-L1 expression in lung cancer cell lines was significantly upregulated by co-culture with M2-differentiated macrophages; expression of PD-L1 was reduced to baseline levels following treatment with a transforming growth factor-ß inhibitor. These results demonstrated that tumor-infiltrating TAM are extrinsic regulators of tumor PD-L1 expression, indicating that combination therapy targeting both tumor PD-L1 and stromal TAM might be a possible strategy for effective treatment of lung cancer.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Regulación hacia Arriba / Antígeno B7-H1 / Adenocarcinoma del Pulmón / Neoplasias Pulmonares Tipo de estudio: Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Año: 2020 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Regulación hacia Arriba / Antígeno B7-H1 / Adenocarcinoma del Pulmón / Neoplasias Pulmonares Tipo de estudio: Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Año: 2020 Tipo del documento: Article